Aulin L B S, Liakopoulos A, van der Graaf P H, Rozen D E, van Hasselt J G C. 2021. Design principles of collateral sensitivity-based dosing strategies. Nature Communications, 12, 5691.

Cai J, Shi J, Chen C, He M, Wang Z, Liu Y. 2023. Structural-activity relationship-inspired the discovery of saturated fatty acids as novel colistin enhancers. Advanced Science, 10, e2302182.

Cao M, Feng Y, Wang C, Zheng F, Li M, Liao H, Mao Y, Pan X, Wang J, Hu D, Hu F, Tang J. 2011. Functional definition of LuxS, an autoinducer-2 (AI-2) synthase and its role in full virulence of Streptococcus suis serotype 2. Journal of Microbiology, 49, 1000–1011.

Chen X W, Wu J H, Liu Y L, Munang’andu H M, Peng B. 2023. Fructose promotes ampicillin killing of antibiotic-resistant Streptococcus agalactiae. Virulence, 14, 2180938.

CLSI 2020. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals: Approved Standard. 5th ed. Wayne: Clinical and Laboratory Standards Institute (CLSI) Supplement VET01S.

Dong C L, Wu T, Dong Y, Qu Q W, Chen X Y, Li Y H. 2024. Exogenous methionine contributes to reversing the resistance of Streptococcus suis to macrolides. Microbiology Spectrum, 12, e0280323.

Dong X, Chao Y, Zhou Y, Zhou R, Zhang W, Fischetti V A, Wang X, Feng Y, Li J. 2021. The global emergence of a novel Streptococcus suis clade associated with human infections. EMBO Molecular Medicine, 13, e13810.

Dou Q, Zhu Y, Li C, Bian Z, Song H, Zhang R, Wang Y, Zhang X, Wang Y. 2023. 4F-indole enhances the susceptibility of Pseudomonas aeruginosa to aminoglycoside antibiotics. Microbiology Spectrum, 11, e0451922.

Feng Y, Zhang H, Ma Y, Gao G F. 2010. Uncovering newly emerging variants of Streptococcus suis, an important zoonotic agent. Trends in Microbiology, 18, 124–131.

Feng Y, Zhang H, Wu Z, Wang S, Cao M, Hu D, Wang C. 2014. Streptococcus suis infection. Virulence, 5, 477–497.

Fuentes-Hernandez A, Plucain J, Gori F, Pena-Miller R, Reding C, Jansen G, Schulenburg H, Gudelj I, Beardmore R. 2015. Using a sequential regimen to eliminate bacteria at sublethal antibiotic dosages. PLoS Biology, 13, e1002104.

Gianvecchio C, Lozano N A, Henderson C, Kalhori P, Bullivant A, Valencia A, Su L, Bello G, Wong M, Cook E, Fuller L, Neal III J B, Yeh P J. 2019. Variation in mutant prevention concentrations. Frontiers in Microbiology, 10, 42.

Gonzales P R, Pesesky M W, Bouley R, Ballard A, Biddy B A, Suckow M A, Wolter W R, Schroeder V A, Burnham C A, Mobashery S, Chang M, Dantas G. 2015. Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA. Nature Chemical Biology, 11, 855–861.

Haenni M, Lupo A, Madec J Y. 2018. Antimicrobial resistance in Streptococcus spp. PLoS Biology, 6, 10.

Hasan M, Wang J, Ahn J. 2023. Ciprofloxacin and tetracycline resistance cause collateral sensitivity to aminoglycosides in Salmonella typhimurium. Antibiotics, 12, 1335.

Hernando-Amado S, Sanz-García F, Martínez J L. 2020. Rapid and robust evolution of collateral sensitivity in Pseudomonas aeruginosa antibiotic-resistant mutants. Advanced Science, 6, eaba5493.

van Hout J, Heuvelink A, Gonggrijp M. 2016. Monitoring of antimicrobial susceptibility of Streptococcus suis in the Netherlands, 2013–2015. Veterinary Microbiology, 194, 5–10.

Imamovic L, Ellabaan M M H, Dantas Machado A M, Citterio L, Wulff T, Molin S, Krogh Johansen H, Sommer M O A. 2018. Drug-driven phenotypic convergence supports rational treatment strategies of chronic infections. Cell, 172, 121–134.

Imamovic L, Sommer M O. 2013. Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Science Translational Medicine, 5, 204ra132.

Lázár V, Pal Singh G, Spohn R, Nagy I, Horváth B, Hrtyan M, Busa-Fekete R, Bogos B, Méhi O, Csörgő B, Pósfai G, Fekete G, Szappanos B, Kégl B, Papp B, Pál C. 2013. Bacterial evolution of antibiotic hypersensitivity. Molecular Systems Biology, 9, 700.

Lee W, Hwang J S, Lee D G. 2015. A novel antimicrobial peptide, scolopendin, from Scolopendra subspinipes mutilans and its microbicidal mechanism. Biochimie, 118, 176–184.

Li Q, Chen S, Zhu K, Huang X, Huang Y, Shen Z, Ding S, Gu D, Yang Q, Sun H, Hu F, Wang H, Cai J, Ma B, Zhang R, Shen J. 2022. Collateral sensitivity to pleuromutilins in vancomycin-resistant Enterococcus faecium. Nature Communications, 13, 1888.

Liakopoulos A, Aulin L B S, Buffoni M, Fragkiskou E, van Hasselt J G C, Rozen D E. 2022. Allele-specific collateral and fitness effects determine the dynamics of fluoroquinolone resistance evolution. Proceedings of the National Academy of Sciences of the United States of America, 119, e2121768119.

Liu Y, Jia Y, Yang K, Li R, Xiao X, Zhu K, Wang Z. 2020. Metformin restores tetracyclines susceptibility against multidrug resistant bacteria. Advanced Science, 7, 1902227.

Liu Y, Tong Z, Shi J, Jia Y, Deng T, Wang Z. 2021. Reversion of antibiotic resistance in multidrug-resistant pathogens using non-antibiotic pharmaceutical benzydamine. Communications Biology, 4, 1328.

Ma X, Xi W, Yang D, Zhao L, Yu W, He Y, Ni W, Gao Z. 2023. Collateral sensitivity between tetracyclines and aminoglycosides constrains resistance evolution in carbapenem-resistant Klebsiella pneumoniae. Drug Resistance Updates, 68, 100961.

Mai N T, Hoa N T, Nga T V, Linh L D, Chau T T, Sinh D X, Phu N H, Chuong L V, Diep T S, Campbell J, Nghia H D, Minh T N, Chau N V, de Jong M D, Chinh N T, Hien T T, Farrar J, Schultsz C. 2008. Streptococcus suis meningitis in adults in Vietnam. Clinical Infectious Diseases, 46, 659–667.

Mei J, Jiang X, Li F, Wu Z, Wu T, Zhu J, Jiang H, Li Z, Li N, Lei L. 2025. Streptococcus suis serotype 2 collagenase-like protease promotes meningitis by increasing blood–brain barrier permeability. Journal of Integrative Agriculture, 24, 4379-4394.

Pan Z, He P, Zhang Y, Gu Q, Chen S, Yu Y, Shao J, Wang K, Wu Z, Yao H, Ma J. 2022. SssP1, a Fimbria-like component of Streptococcus suis, binds to the vimentin of host cells and contributes to bacterial meningitis. PLoS Pathogens, 18, e1010710.

Qu Q, Cui W, Huang X, Zhu Z, Dong Y, Yuan Z, Dong C, Zheng Y, Chen X, Yuan S, Li Y. 2023. Gallic acid restores the sulfonamide sensitivity of multidrug-resistant Streptococcus suis via polypharmaceology mechanism. Journal of Agricultural and Food Chemistry, 71, 6894–6907.

Roemhild R, Andersson D I. 2021. Mechanisms and therapeutic potential of collateral sensitivity to antibiotics. PLoS Pathogens, 17, e1009172.

Roemhild R, Linkevicius M, Andersson D I. 2020. Molecular mechanisms of collateral sensitivity to the antibiotic nitrofurantoin. PLoS Biology, 18, e3000612.

Segura M. 2009. Streptococcus suis: An emerging human threat. Journal of Infectious Diseases, 199, 4–6.

Segura M. 2015. Streptococcus suis vaccines: Candidate antigens and progress. Expert Review of Vaccines, 14, 1587–1608.

Shi K, Li Y, Xu M, Zhang K, Gou H, Li C, Zhai S. 2024. Membrane vesicles derived from Streptococcus suis serotype 2 induce cell pyroptosis in endothelial cells via the NLRP3/Caspase-1/GSDMD pathway. Journal of Integrative Agriculture, 23, 1338-1353.

Stautz J, Hellmich Y, Fuss M F, Silberberg J M, Devlin J R, Stockbridge R B, Hänelt I. 2021. Molecular mechanisms for bacterial potassium homeostasis. Journal of Molecular Biology, 433, 166968.

Szybalski W, Bryson V. 1952. Genetic studies on microbial cross resistance to toxic agents. I. Cross resistance of Escherichia coli to fifteen antibiotics. Journal of Bacteriology, 64, 489–499.

Tang J, Wang C, Feng Y, Yang W, Song H, Chen Z, Yu H, Pan X, Zhou X, Wang H, Wu B, Wang H, Zhao H, Lin Y, Yue J, Wu Z, He X, Gao F, Khan A H, Wang J, et al. 2006. Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. PLoS Medicine, 3, e151.

Toutain P L, Pelligand L, Lees P, Bousquet-Mélou A, Ferran A A, Turnidge J D. 2021. The pharmacokinetic/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: Recent advances and critical appraisal. Journal of Veterinary Pharmacology and Therapeutics, 44, 172–200.

Wang C Z, Wang M G, Chu Y F, Sun R Y, Li J G, Li X A, Sun J, Liu Y H, Zhou Y F, Liao X P. 2023. Antibiotic resistance patterns and molecular characterization of Streptococcus suis Isolates from swine and humans in China. Microbiology Spectrum, 11, e0030923.

Wang R L, Liu P, Chen X F, Yao X, Liao X P, Liu Y H, Sun J, Zhou Y F. 2022. Pharmacodynamic target assessment and PK/PD cutoff determination for gamithromycin against Streptococcus suis in piglets. Frontiers in Veterinary Science, 9, 945632.

Wei X Y, Zhang J, Zhang Y, Fu W Z, Zhong L G, Pan Y D, Sun J, Liao X P, Liu Y H, Zhou Y F. 2024. Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis. BMC Veterinary Research, 20, 147.

Weng Z, Zeng F, Wang M, Guo S, Tang Z, Itagaki K, Lin Y, Shen X, Cao Y, Duan J A, Wang F. 2023. Antimicrobial activities of lavandulylated flavonoids in Sophora flavences against methicillin-resistant Staphylococcus aureus via membrane disruption. Journal of Advanced Research, 57, 197–212.

Wertheim H F, Nghia H D, Taylor W, Schultsz C. 2009. Streptococcus suis: An emerging human pathogen. Clinical Infectious Diseases, 48, 617–625.

Wyns H, Meyer E, Plessers E, Watteyn A, De Baere S, De Backer P, Croubels S. 2014. Pharmacokinetics of gamithromycin after intravenous and subcutaneous administration in pigs. Research in Veterinary Science, 96, 160–163.

Xia X, Qin W, Zhu H, Wang X, Jiang J, Hu J. 2019. How Streptococcus suis serotype 2 attempts to avoid attack by host immune defenses. Journal of Microbiology, Immunology, and Infection. 52, 516–525.

Yang B, Tong Z, Shi J, Wang Z, Liu Y. 2023. Bacterial proton motive force as an unprecedented target to control antimicrobial resistance. Medicinal Research Reviews, 43, 1068–1090.

Yang Q, Liu X, Zhang C, Yong K, Clifton A C, Ding H, Liu Y. 2019. Pharmacokinetics and pharmacodynamics of gamithromycin treatment of Pasteurella multocida in a murine lung infection model. Frontiers in Pharmacology, 10, 1090.

Yoshida M, Reyes S G, Tsuda S, Horinouchi T, Furusawa C, Cronin L. 2017. Time-programmable drug dosing allows the manipulation, suppression and reversal of antibiotic drug resistance in vitro. Nature Communications, 8, 15589.

Yu H, Jing H, Chen Z, Zheng H, Zhu X, Wang H, Wang S, Liu L, Zu R, Luo L, Xiang N, Liu H, Liu X, Shu Y, Lee S S, Chuang S K, Wang Y, Xu J, Yang W. 2006. Human Streptococcus suis outbreak, Sichuan, China. Emerging Infectious Diseases, 12, 914–920.

Zhao Z, Wen S, Song N, Wang L, Zhou Y, Deng X, Wu C, Zhang G, Chen J, Tian G B, Liang M, Zhong L L. 2023. Arginine-enhanced antimicrobial activity of nanozymes against gram-negative bacteria. Advanced Healthcare Materials, 13, e2301332.

Zheng C, Wei M, Jia M, Cao M. 2020. Involvement of various enzymes in the physiology and pathogenesis of Streptococcus suis. Veterinary Sciences, 7, 143.

Zhou Y F, Bu M X, Liu P, Sun J, Liu Y H, Liao X P. 2020. Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets. BMC Veterinary Research, 16, 81.